Andon Health Co Ltd

Andon Health announced that Yibin Dingfeng Venture Capital Partnership, in which it participates as a limited partner, has completed its fundraising. All partners have fully paid their subscribed capital contributions, with total paid-in capital amounting to 1.05 billion yuan. The company contributed 70 million yuan, representing 6.67% of the subscribed capital. The fund is managed by Jiaxing Wuyuefeng Investment Management as the fund manager, with Jiashan Dingfeng Zhishan Venture Capital Partnership serving as the general partner. The company disclosed its participation in the investment in September 2022, and the fund completed its registration in January 2023.

Andon Health disclosed that its wholly-owned subsidiary, Andon Hong Kong, indirectly invested in Hangzhou DeepSeek Artificial Intelligence Basic Technology Research Co., Ltd. through Tianjin Shixiang Investment Partnership, with an investment amount of 750 million yuan. The paid-in capital contribution has been completed, and the indirect shareholding ratio after look-through is approximately 0.21%. The company stated that the shareholding ratio is very low, it does not participate in the target company's operations and cannot exert control over it, and its right to know and influence over the target company's actual operating conditions, financial data, major decisions, and potential risk matters is limited. The above investment features a long payback period and low liquidity, and objectively carries the risk of not being able to exit in a timely and effective manner. The company's recent fundamentals have not undergone significant changes, but the stock price has experienced substantial fluctuations due to factors such as market sentiment and concept speculation, and there is a risk of future stock price volatility and decline.